OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Put a ring on it: application of small aliphatic rings in medicinal chemistry	166
Macrocyclization strategies for cyclic peptides and peptidomimetics	74
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis	73
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics	56
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates	54
Recent developments on MOF-based platforms for antibacterial therapy	51
Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies	49
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors	46
Target 2035 – update on the quest for a probe for every protein	39
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors	38
A review of the latest research on M^pro targeting SARS-COV inhibitors	37
Fragment-based drug discovery: opportunities for organic synthesis	35
Aloe-emodin derived azoles as a new structural type of potential antibacterial agents: design, synthesis, and evaluation of the action on membrane, DNA, and MRSA DNA isomerase	31
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch	30
Recent advances in the development of covalent inhibitors	30
Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase	28
Polarity-based fluorescence probes: properties and applications	27
Ruthenium(ii)–arene complexes as anti-metastatic agents, and related techniques	27
Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides	23
Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives	22
Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots	21
Human carboxylesterases and fluorescent probes to image their activity in live cells	21
Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs	21
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers	21
Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activity	21

Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies